Drug intelligence / Profile preview

Ear Itch MD Plus

Development stage
Unknown
Lead developer
EOSERA
Modality
Small Molecules
Administration
Otic, Topical
01

Overview

Ear Itch MD Plus (also known as Ear Itch MD +PLUS) is an over-the-counter (OTC) topical anti-itch ear spray developed by Eosera. The active ingredient is hydrocortisone 1%, a low-potency corticosteroid that acts as an agonist of the glucocorticoid receptor. By binding to the glucocorticoid receptor, hydrocortisone modulates gene transcription to reduce the synthesis of pro-inflammatory mediators and increase the expression of anti-inflammatory proteins. This action effectively suppresses inflammatory and allergic skin responses, providing temporary relief from itching, irritation, and inflammation in and around the ear canal. Ear Itch MD Plus is indicated for minor skin irritations, eczema, psoriasis, dermatitis, and rashes in or around the ear, and is formulated with soothing inactive ingredients such as aloe, colloidal oatmeal, and turmeric.

Brand names
Ear Itch MD +PLUSEar Itch MD PlusEosera Ear Itch MD Plus
Other names
hydrocortisone 1%hydrocortisone 1% otic sprayhydrocortisone 1% spray
02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on Ear Itch MD Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ear Itch MD Plus.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call